MedPath

Study of Bipolar Disorders and Retinal Electrophysiological Markers

Not Applicable
Terminated
Conditions
Bipolar Disorder
Registration Number
NCT05161546
Lead Sponsor
Centre Psychothérapique de Nancy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Terminated
Sex
All
Target Recruitment
62
Inclusion Criteria

Inclusion criteria :<br><br> 1. Patients:<br><br> - been diagnosed with BD according to the Diagnostic and Statistical Manual of<br> Mental Disorders - 4th edition (DSM-IV) diagnostic criteria using the Mini<br> International Neuropsychiatric Interview (MINI)<br><br> - currently euthymic for at least 3 months prior to the study, as defined by a<br> score below 10 on the Montgomery-Asberg Depression Rating Scale (MADRS) which<br> assesses depression and by a score below 8 on the Young Mania Rating Scale<br> (YMRS) which assesses mania<br><br> - age 18 or more<br><br> 2. Healthy volunteers:<br><br> - not suffer from a personal psychiatric pathology verified with the MINI<br><br> - age 18 or more<br><br>Exclusion criteria for all participants (patients and healthy volunteers):<br><br> - suffer from psychiatric pathology or substance use disorders according to DSM-IV<br> criteria measured with the MINI, excluding BD for the patient group<br><br> - suffer from neurological or retinal pathology<br><br> - having a shift work or a get-lag in the last 15 days<br><br> - criteria incompatible with the use of the virtual reality headset<br> (Retinaute®,BioSerenity) like having an allergy to one of the components of the<br> textile<br><br> - persons treated by sismotherapy during the past year<br><br> - persons with an uncorrected visual impairment or disabling hearing impairment that<br> does not allow neuropsychological tests to be performed<br><br> - subjects with an intellectual disability making it difficult to participate in the<br> study or to understand and follow informations provided to them<br><br> - adults legally protected<br><br> - pregnant or breastfeeding women<br><br> - subjects already participating in another interventional trial

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Modification of amplitude measured with flash and pattern electroretinogram;Modification of implicite time measured with flash and pattern electroretinogram
Secondary Outcome Measures
NameTimeMethod
Modification of amplitude measured with electroencephalogram;Modification of latency measured with electroencephalogram;Actigraphy;Sleep diary;Visual Object and Space Perception battery (VOSP);California Verbal Learning Test (CVLT);Continuous Performance Task (CPT-III);Verbal Fluency Task;Test of Attention Assessment (TAP);Montreal Cognitive Assessment (MoCA)
© Copyright 2025. All Rights Reserved by MedPath